Clinical Trials Search

Titlesort descending Intervention NCT ID Sponsor Status
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast... oral placebo, afimoxifene, tamoxifen citrate, placebo gel NCT00952731 Northwestern University Completed
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration NCT02933489 ECOG-ACRIN Cancer Research Group Active, not recruiting
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention NCT00983580 National Cancer Institute (NCI) Active, not recruiting
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Aspirin, Laboratory Biomarker Analysis, Placebo NCT02169271 National Cancer Institute (NCI) Active, not recruiting
Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer acolbifene hydrochloride NCT00853996 University of Kansas Medical Center Completed
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing... Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study, Placebo NCT02917629 National Cancer Institute (NCI) Recruiting
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Real Acupressure Band, Placebo Acupressure Band NCT01346267 University of South Florida Completed
Acute Pain Caused by Paclitaxel in Patients With Cancer pain questionnaires NCT00860041 Alliance for Clinical Trials in Oncology Completed
Adaptation of Individual Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients Adaptation of IMCP for Chinese Immigrant Cancer Patients, In-depth Patient Interviews NCT02112188 Memorial Sloan Kettering Cancer Center Completed
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting